week in cancer news

0 Comments

A trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.

by Kate Yandell

0 Comments

A study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.

by Kate Yandell

0 Comments

A study links adolescent obesity to adult pancreatic cancer risk, and “Batkid” turns 10 years old.

by Bradley Jones

0 Comments

A study assesses how timing affects the outcomes of pregnancy after cancer treatment, and researchers present on the benefits of Medicaid expansion for breast cancer patients.

by Kate Yandell

0 Comments

A survey shows that 39 percent of Americans believe that alternative therapies can cure cancer, and a trial finds that minimally invasive surgery is inferior to traditional surgery for treating cervical cancer.

by Kate Yandell

0 Comments

Researchers present cancer clinical trial results at the ESMO 2018 Congress, and a study shows that crowdfunding campaigns are raising money for unproven cancer treatments.

by Kate Yandell

0 Comments

A study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.

by Kate Yandell

0 Comments

A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.

by Kate Yandell

0 Comments

Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.

by Kate Yandell

0 Comments

A study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.

by Kate Yandell